Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants

Free Radical Biology and Medicine

Volumn 34, Issue 8, 2003, Pages 1070-1077

  Veurink, Gerald ^a,b   Liu, Dan ^a,b,c   Taddei, Kevin ^a,b   Perry, George ^d   Smith, Mark A ^d   Robertson, Terry A ^a,b   Hone, Eugene ^a   Groth, David M ^e   Atwood, Craig S ^d   Martins, Ralph N ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CURTIN UNIVERSITY   (Australia)

Author keywords

Aging; Alzheimer's disease; Antioxidants; ApoE deficient mice; Apoptosis; Free radicals; Inclusion bodies; Life span; Longevity; Neurodegeneration; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBYL PALMITATE; DNA FRAGMENT; GINKGO BILOBA EXTRACT; PYCNOGENOL;

AGING; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; LIFESPAN; LONGEVITY; MOUSE; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

FELIS CATUS; GINKGO BILOBA;

EID: 0037446366     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00042-X     Document Type: Article

References (39)

1. Kitani K., Kanai S., Ivy G.O., Carrillo M.C. Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models. Ann. NY Acad. Sci. 854:1998;291-306.
2. Melov S., Ravenscroft J., Malik S., Gill M.S., Walker D.W., Clayton P.E., Wallace D.C., Malfroy B., Doctrow S.R., Lithgow G.J. Extension of life span with superoxide dismutase/catalase mimetics. Science. 289:(5484):2000;1567-1569.
3. Atwood C.S., Huang X., Moir R.D., Tanzi R.E., Bush A.I. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met. Ions Biol. Sys. 36:1999;309-364.
4. Martins R.N., Harper C.G., Stokes G.B., Masters C.L. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46:1986;1042-1045.
5. Perry G., Smith M.A. Is oxidative damage central to the pathogenesis of Alzheimer's disease? Acta Neurol. Belg. 98:1998;175-179.
6. Perry G., Raina A.K., Nunomura A., Wataya T., Sayre L.M., Smith M.A. How important is oxidative damage? Lessons from Alzheimer's disease. Free Radic. Biol. Med. 28:(5):2000;831-834.
7. Sayre L.M., Smith M.A., Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:2001;721-738.
8. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336:1997;1216-1222.
9. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 48:1997;626-632.
10. Kanowski S., Hermann W.M., Stephan K., Wierich W., Horr R. Proof of efficacy of the ginkgo biloba special extract Egb-761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 29:1996;47-56.
11. Tang M., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
12. Paleologos M., Cumming R.G., Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am. J. Epidemiol. 148:1998;45-50.
13. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17:1996;673-680.
14. Wong A., Dukic-Stefanovic S., Gasic-Milenkovic J., Schinzel R., Wiesinger H., Riederer P., Munch G. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation end products in murine microglia. Eur. J. Neurosci. 14:2001;1961-1967.
15. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nature Gen. 14:1996;55-61.
16. Robertson T.A., Dutton N.S., Martins R.N., Roses A.D., Kakulas B.A., Papadimitriou J.M. Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice. Neuroscience. 82:1998;171-180.
17. Akiyama H., Kameyama M., Akiguchi I., Sugiyama H., Kawamata T., FukuYama H., Kimura H., Matsushita M., Takeda T. Periodic acid-Schiff- (PAS-) positive granular structures increase in the brain of senescence-accelerated mouse (SAM). Acta Neuropathol. 72:1986;124-129.
18. Jucker M., Walker L.C., Schwarb P., Hengemihle J., Kuo H., Snow A.D., Bamert F., Ingram D.K. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience. 60:1994;875-889.
19. 10, β-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic. Biol. Med. 18:1995;949-953.
20. Crawford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:1998;1506-1513.
21. Yang D.S., Small D.H., Seydel U., Smith J.D., Hallmayer J., Gandy S.E., Martins R.N. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience. 90:(4):1999;1217-1226.
22. Simons M., Keller P., Dichgans J., Schulz J.B. Cholesterol and Alzheimer's disease is there a link . Neurology. 57:2001;1089-1093.
23. Sparks D.L. Dietary cholesterol induces Alzheimer-like β-amyloid immunoreactivity in rabbit brain. Nutr. Metab. Cardiovasc. Dis. 7:1997;255-266.
24. Cummings B.J., Satou T., Head E., Milgram N.W., Cole G.M., Savage M.J., Podlisny M.B., Selkoe D.J., Siman R., Greenberg B.D., Cotman C.W. Diffuse plaques contain C-terminal A β 42 and not A β 40 evidence from cats and dogs . Neurobiol. Aging. 17:1996;653-659.
25. Wisniewski H.M., Johnson A.B., Raine C.S., Kay W.J., Terry R.D. Senile plaques and cerebral amyloidosis in aged dogs. Lab. Invest. 23:1970;287-296.
26. Tekirian T.L., Cole G.M., Russell M.J., Yang F., Wekstein D.R., Patel E., Snowdon D.A., Markesbery W.R., Geddes J.W. Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol. Aging. 17:1996;249-257.
27. Wisniewski H.M., Ghetti B., Terry R.D. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J. Neuropathol. Exp. Neurol. 32:1973;566-584.
28. Masliah E., Westland C.E., Rockenstein E.M., Abraham C.R., Mallory M., Veinberg I., Sheldon E., Mucke L. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience. 78:1997;135-146.
29. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKeel D.W., Morris J.C. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease. Arch. Neurol. 58:(9):2001;1395-1402.
30. Sparks D.L., Scheff S.W., Hunsaker J.C., Liu H., Landers T., Gross D.R. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126:(1):1994;88-94.
31. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:(6):1999;1959-1964.
32. Raina A.K., Perry G., Nunomura A., Sayre L.M., Smith M.A. Histochemical and immunocytochemical approaches to the study of oxidative stress. Clin. Chem. Lab. 38:(2):2000;93-97.
33. Smith M.A., Nunomura A., Zhu X., Takeda A., Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer's disease. Antioxid. Redox Signal. 2:(3):2000;413-420.
34. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21:(9):2001;3017-3023.
35. Evangelou A., Kalpouzos G., Karkabounas S., Liasko R., Nonni A., Stefanou D., Kallistratos G. Dose-related preventive and therapeutic effects of antioxidants/anticarcinogens on experimentally induced malignant tumors in Wistar rats. Cancer Lett. 115:(1):1997;105-111.
36. Galley H.F., Thornton J., Howdle P.D., Walker B.E., Webster N.R. Combination oral antioxidant supplementation reduces blood pressure. Clin. Sci. (Colch.). 92:(4):1997;361-365.
37. Knudsen C.A., Tappel A.L., North J.A. Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. Free Radic. Biol. Med. 20:(2):1996;165-173.
38. Fonte J., Miklossy J., Atwood C., Martins R. The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-β levels resolubilization of amyloid-β with transition metal ion chelators . J. Alzheimers Dis. 3:2001;209-219.
39. Hager K., Marahrens A., Kenklies M., Riederer P., Munch G. Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Arch. Gerontol. Geriatr. 32:2001;275-282.